The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 20.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it strong buy, with a mean price target of $252.
Regal Rexnord Corp
RRX · the NYSE · USD · Market cap $10.7B · 30,000 employees
Regal Rexnord Corporation provides sustainable solutions for power, transmit, and control motion products in the North America, Asia, Europe, and internationally.
FAIL · Does not pass the screenAt the last full screen
2026-09-02
Screened 2026-09-02 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Regal Rexnord Corp holds its Markdown at $160.77. Consolidating, no directional conviction, held for 3 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 3 days |
| Price at the screen | $160.77 |
| Valuation | 33.01 trailing · 12.30 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.07 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 35.49% | Below 33% | Interest-bearing debt is 35.5% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 7.51% | Below 49% | Money owed to the company is 7.5% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.40% | Below 5% | Only 0.4% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-02 screen. The gold marker is the market price at the same screen. A 56.7% margin of safety to the base estimate.
Third-party analyst targets: 10 covering, consensus Strong Buy. The average target sits +51% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-02 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsFactory Motors That Fail to Turn Heads
Every factory line depends on the gears and motors that shift power from one station to the next. Regal Rexnord sits in that space yet posts revenue growth of just 4 percent, a 5 percent profit margin and 4 percent return on equity. We pass because those returns sit too low for a narrow moat business trading at 15.3 times forward earnings.
The shares trade at 206 dollars against our 264 dollar fair value, a 28 percent margin of safety, and nine analysts carry a strong buy call with a 260 dollar median target. Still the numbers point to a company that does not compound capital efficiently enough to justify ownership.
Risk sits in the narrow competitive position that leaves it open to larger rivals and in the low returns that suggest any upturn could prove fleeting. The ethical screen clears, yet the opportunity does not appear. Analysis, not advice.
| Forward P/E | 12.3xexpensive even after accounting for its growth |
| Trailing P/E | 33.0xa premium valuation |
| EPS, trailing | 4.87 |
| EPS, forward | 13.07 |
| Revenue growth | +4.2%slow but positive growth |
| Profit margin | 5.3%thin but positive margins |
| Return on equity | 4.8%a modest return on shareholder capital |
| FCF yield | 4.25% |
| Dividend yield | 66.00% |
| Debt to equity | 0.69moderate, manageable leverage |
| Current ratio | 2.28comfortably covers its short-term bills |
| Beta | 1.07moves a little more than the market |
| Short interest, float | 0.05% |
| 52-week range | 127.96 - 247.80 |
| Moat | NARROW |
| Market cap | $10.7B |
| Employees | 30,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeRRX trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it strong buy, with a mean price target of $252.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it strong buy, with a mean price target of $252.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $211.33 | -5.2% | · | $948 | -5.2% |
| 2 months | $208.33 | -3.8% | · | $962 | -3.8% |
| 3 months | $187.26 | +7.0% | $0.35 | $1,072 | +7.2% |
| 6 months | $151.99 | +31.8% | $0.70 | $1,323 | +32.3% |
| 1 year | $142.63 | +40.5% | $1.40 | $1,415 | +41.5% |
| 2 years | $139.85 | +43.3% | $2.80 | $1,453 | +45.3% |
| 3 years | $141.28 | +41.8% | $4.20 | $1,448 | +44.8% |
| 5 years | $124.88 | +60.4% | $13.91 | $1,716 | +71.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever RRX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.